Results 131 to 140 of about 25,074 (200)

Myocardial infarction as a thrombotic complication of myeloproliferative disorders. [PDF]

Anatol J Cardiol, 2016
Petrou E, Karali V.
europepmc   +1 more source

Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study. [PDF]

Blood Adv, 2018
Sengsayadeth S, Gatwood KS, Boumendil A, Labopin M, Finke J, Ganser A, Stelljes M, Ehninger G, Beelen D, Niederwieser D, Blaise D, Dreger P, Mufti G, Chevallier P, Mailhol A, Gilleece MH, Gorin N, Esteve J, Ciceri F, Baron F, Schmid C, Giebel S, Mohty M, Savani BN, Nagler A.   +24 more
europepmc   +1 more source

Pulmonary hypertension in patients with chronic myeloproliferative disorders. [PDF]

Eur Respir Rev, 2015
Adir Y, Elia D, Harari S.
europepmc   +1 more source

Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study. [PDF]

Biol Blood Marrow Transplant, 2019
Gupta V, Kosiorek HE, Mead A, Klisovic RB, Galvin JP, Berenzon D, Yacoub A, Viswabandya A, Mesa RA, Goldberg J, Price L, Salama ME, Weinberg RS, Rampal R, Farnoud N, Dueck AC, Mascarenhas JO, Hoffman R.   +17 more
europepmc   +1 more source

Ocular manifestations in leukemia and myeloproliferative disorders and their association with hematological parameters. [PDF]

Ann Afr Med, 2016
Dhasmana R, Prakash A, Gupta N, Verma SK.   +3 more
europepmc   +1 more source

Ophthalmological and epidemiological profiles of Brazilian patients with philadelphia-negative Myeloproliferative neoplasms. [PDF]

Hematol Transfus Cell Ther
Piloni-Parreira R, Barbosa MS, Neves LL, Santana HL, Rodrigues JMRDS, Tavares RS, Isaac DLC, Pereira de Ávila M.   +7 more
europepmc   +1 more source

Back to biology: new insights on inheritance in myeloproliferative disorders. [PDF]

Curr Hematol Malig Rep, 2014
Braunstein EM, Moliterno AR.
europepmc   +1 more source

ATM mutations in myelodysplastic neoplasms, acute myeloid leukemia, and myeloproliferative neoplasms: a systematic review. [PDF]

Med Oncol
Laurindo LO, Parente MLB, Sasahara GL, Goes JVC, Sampaio LR, Pinheiro YV, Pinheiro RF.   +6 more
europepmc   +1 more source

Modifiable determinants of adherence to tyrosine kinase inhibitors in classical myeloproliferative neoplasms: A mixed-methods systematic review protocol. [PDF]

PLoS One
Inouye FC, Teo V, Clarke J, Georgopoulou S, Freato Gonçalves AMR, de Figueiredo-Pontes LL, Régis Leira Pereira L, Chapman S.   +7 more
europepmc   +1 more source